Understanding the Major Workplace Causes of Cancer in Canada Date held: April 25, 2019 Presented by: Dr. Paul Demers, Director of the Occupational Cancer Research Centre and Professor with the University of Toronto Webinar Information: Every year in Canada thousands of people are diagnosed with cancer caused by their work and millions of people continue to be exposed to workplace carcinogens. In this webinar, Dr.
Website brings together resources for cancer survivors, healthcare providers, and employers to support staying and returning to work Returning to work after any illness can be a challenge. For cancer survivors, the return to work (RTW) can be especially difficult due to the effects of cancer and its treatment. Employers may lack understanding of cancer’s impact on work abilities, and how to provide accommodations
Lisa MacLeod, MPP (Nepean-Carleton) brought forward a Private Members’ Motion on October 20th, to address the funding gap for patients in exceptional circumstances through the consideration of a compassionate catastrophic care fund. She tabled the motion regarding a Catastrophic and Compassionate Care fund on October 20, 2016, followed by a media conference in the media studio at Queen’s Park, where she was joined by PC Health Critic
CanCertainty calling on our Provincial Health Ministers to listen to a growing number of cancer patients, caregivers, families, and healthcare professionals who want to see every province treat oral (and injectable) cancer drugs on par with those given in hospitals intravenously. Cancer is Cancer — and all cancer treatments should be funded and managed equally — as they are in Western Canada. Beginning in Ontario,
Earlier this month, Crohn’s and Colitis Canada launched a public action campaign around patient choice. While they celebrate the introduction of biosimilars as a treatment choice for people living with Crohn’s or colitis, they also want to ensure that the medication decisions remain between the doctor and his/her patient. As you may know, some provincial drug plans are considering forcing stable patients to switch their
Researchers in Montreal have developed a new way of administering cancer-fighting drugs directly into tumours, using something they call “bacteria-based nanorobots.” The approach has so far been successfully tested only in mice, but the researchers say the new technique could be an effective way to fight resistant tumours that are currently considered not curable. Researchers from Polytechnique Montréal, Université de Montréal and McGill